Veeva Systems A Stock
Veeva Systems A Stock
Our community is currently high on Veeva Systems A with 5 Buy predictions and 1 Sell predictions.
With a target price of €250.00 there is a slightly positive potential of 4.123% for Veeva Systems A compared to the current price of €240.10.
So far the community has only identified positive things for Veeva Systems A stock. The most positive votes were given for criterium "Customer and product portfolio".
Pros and Cons of Veeva Systems A in the next few years
Pros
Cons
Performance of Veeva Systems A vs. its peers
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Veeva Systems A | 0.020% | 4.687% | 2.651% | 82.378% | 6.498% | 408.686% | - |
| Waters Corp. | -0.880% | -0.885% | 9.804% | 3.704% | 10.891% | 30.233% | 91.764% |
| Cerner Corp. | -0.150% | 1.983% | 4.928% | -0.977% | 4.387% | 21.564% | 26.485% |
| Varian Medical Systems Inc. | -1.380% | 0.000% | 0.694% | 7.407% | 1.399% | 39.423% | 172.096% |
Comments
Other discussions about Veeva Systems A Stock
Trading Veeva Systems A
Trading Veeva Systems A
News
Veeva Becomes First Public Company to Convert to a Public Benefit Corporation
Veeva Systems (NYSE: VEEV) announced that in an overwhelming majority vote, 99% of voting shareholders support the company’s proposal to become a public benefit corporation (PBC), including the
CORRECTING and REPLACING Veeva Becomes First Public Company to Convert to a Public Benefit Corporation
Please replace the release with the following corrected version due to multiple revisions.
The updated release reads:
VEEVA BECOMES FIRST PUBLIC COMPANY TO CONVERT TO A PUBLIC BENEFIT
Integra LifeSciences Selects Veeva Vault CDMS for Clinical Data Management
Veeva Systems (NYSE: VEEV) today announced that Integra LifeSciences, a global leader in regenerative technologies, neurosurgical, and extremity orthopedic solutions, has selected Veeva Vault CDMS
Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management
Veeva Systems (NYSE: VEEV) today announced that Samsung Biologics, an award-winning global contract development and manufacturing organization (CDMO), has adopted Veeva Vault QMS to streamline
Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management
Veeva Systems (NYSE: VEEV) today announced that Samsung Biologics, an award-winning global contract development and manufacturing organization (CDMO), has adopted Veeva Vault QMS to streamline
Simbec-Orion Streamlines Trial Execution with Veeva Clinical Applications
Veeva Systems (NYSE: VEEV) today announced that Simbec-Orion, a full-service contract research organization (CRO) specialized in clinical pharmacology, oncology, and rare diseases, is adopting
Simbec-Orion Streamlines Trial Execution With Veeva Clinical Applications
Veeva Systems (NYSE: VEEV) today announced that Simbec-Orion, a full-service contract research organization (CRO) specialized in clinical pharmacology, oncology, and rare diseases, is adopting
Veeva Announces Fiscal 2021 Third Quarter Results
Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fiscal third quarter ended October 31, 2020.
Veeva Link Expands to 11 New Therapeutic Areas
Veeva Systems (NYSE: VEEV) today announced Veeva Link for 11 new therapeutic areas, including bacterial infections, cardiology, dermatology, endocrinology, gastroenterology, hepatology, nephrology
Veeva Vault PromoMats to Support Bristol Myers Squibb in Speeding Compliant Content to Market
Veeva Systems (NYSE: VEEV) today announced that Bristol Myers Squibb (NYSE: BMY) is adopting Veeva Vault PromoMats to deliver fast, compliant content across all digital channels to meet their
Veeva Link Expands to 11 New Therapeutic Areas
Veeva Systems (NYSE: VEEV) today announced Veeva Link for 11 new therapeutic areas, including bacterial infections, cardiology, dermatology, endocrinology, gastroenterology, hepatology, nephrology
Veeva Vault PromoMats to Support Bristol Myers Squibb in Speeding Compliant Content to Market Engagement
Veeva Systems (NYSE: VEEV) today announced that Bristol Myers Squibb (NYSE: BMY) is adopting Veeva Vault PromoMats to deliver fast, compliant content across all digital channels to meet their
More Than 75 Companies Adopt Veeva Vault CTMS to Accelerate Clinical Research
As the need to improve efficiency and speed in trials grows, more than 75 organizations, including six of the top 20 pharmaceutical companies, are unifying clinical information and processes with
European Survey Shows Quality Customer Reference Data Critical to Digital Engagement
According to new research from Veeva Systems (NYSE: VEEV), customer data is critical to digital transformation initiatives for European life sciences companies. Findings from the Veeva 2020
North America Survey Reveals Better Customer Data Essential to Digital Transformation
Access to quality customer reference data is more important than ever as the life sciences industry shifts to digital engagement, according to new research from Veeva Systems (NYSE: VEEV). Findings
Axsome Therapeutics and Veeva Systems Partner to Build Axsome’s Digital-Centric Commercialization™ Platform
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, and Veeva Systems (NYSE: VEEV), today
Axsome Therapeutics and Veeva Systems Partner to Build Axsome’s Digital-Centric Commercialization™ Platform
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, and Veeva Systems (NYSE: VEEV), today
Digital Leaders from Almirall and Merck KGaA, Darmstadt, Germany to Keynote Veeva Summit Online, Europe
Veeva Systems (NYSE: VEEV) today announced that Dr. Francesca Domenech Wuttke, chief digital officer at Almirall, and Alessandro de Luca, CIO of healthcare at Merck KGaA, Darmstadt, Germany are
Bavarian Nordic Adopting Veeva CRM and Veeva Vault PromoMats for Digital Launch of New Vaccines
Veeva Systems (NYSE: VEEV) today announced that Bavarian Nordic is adopting multichannel Veeva CRM and Veeva Vault PromoMats for the digital launch of new products in the U.S. and Europe, including
Bavarian Nordic Adopting Veeva CRM and Veeva Vault PromoMats for Digital Launch of New Vaccines
Veeva Systems (NYSE: VEEV) today announced that Bavarian Nordic is adopting multichannel Veeva CRM and Veeva Vault PromoMats for the digital launch of new products in the U.S. and Europe, including
Veeva Teams with Life Sciences to Offer Industrywide Source for Key Contacts, Information, and Services from Across Companies and Brands
To help healthcare professionals (HCPs) get provider and patient resources faster, Veeva Systems (NYSE: VEEV), in partnership with the industry, today introduced MyVeeva for Doctors, a mobile
Veeva Teams with Life Sciences to Offer Industrywide Source for Key Contacts, Information, and Services from Across Companies and Brands
To help healthcare professionals (HCPs) get provider and patient resources faster, Veeva Systems (NYSE:VEEV), in partnership with the industry, today introduced MyVeeva for Doctors, a mobile
Chief Medical Officers from Boston Scientific, Illumina, Johnson & Johnson, and QIAGEN to Keynote Veeva MedTech Summit Online
Veeva Systems (NYSE: VEEV) today announced the featured keynote speakers at 2020 Veeva Medical Device & Diagnostics Summit Online. Chief medical officers from Boston Scientific, Illumina, Johnson &
Exact Sciences Selects Veeva Vault Clinical Suite to Help Accelerate Innovation
Veeva Systems (NYSE: VEEV) today announced that Exact Sciences, a leading provider of cancer screening and diagnostic tests, selected Veeva Vault Clinical Suite to design and run its clinical
Roche Selects Veeva Development Cloud Applications
Veeva Systems (NYSE: VEEV) today announced that Roche (SWX: ROG) has selected Veeva Development Cloud applications globally to streamline clinical, regulatory, and quality processes. The company is
